Available cervical cancer vaccines fail to cover the HPV 35 genotype common in Africa

Health Policy Watch news story

HPV35, globally associated with only 2% of invasive cervical cancers (ICC), has a disproportionately higher prevalence in sub‐Saharan Africa, reaching rates of 22-30% in some countries among women with ICC lesions, according to a new study. Recently, a high-level panel called for redoubled efforts in HPV vaccination, screening and treatment to meet the WHO Global Strategy targets for 2030 – and eliminate cervical cancer by 2050 worldwide.

Read the full news story here.

Source : Health Policy Watch